Services
Trend analysis for innovation, FDA and regulatory insights, innovation opportunity assessment, and M&A, divestiture, and transaction support.
The Work
Companies and investors often need to act before all the answers are available, understanding whether an opportunity is real, whether an ingredient or benefit space is becoming credible, whether claims are ownable, whether FDA precedent creates risk, or whether a transaction carries hidden regulatory or quality exposure.
Insight to help leaders decide where to play, what to build, what to claim, and what evidence is needed, integrating competitive activity, ingredient science, benefit trends, regulatory precedent, and claims feasibility.
Services
Detailed information on each service is available on request. Get in touch →
Analysis of FDA Complete Response Letters to surface recurring deficiencies, review-division expectations, approval barriers, and resubmission risk.
Learn More →Assessment of emerging benefit areas, ingredients, consumer territories, scientific support, claims potential, regulatory feasibility, and timing.
Learn More →Category and innovation prioritization across supplements, women's health, longevity, gut health, skin health, postbiotics, and adjacent spaces.
Learn More →Regulatory due diligence, claims and quality risk assessment, management presentation support, diligence Q&A preparation, and post-transaction integration or remediation planning.
Learn More →How We Engage
RGM engagements are designed around the decision the client needs to make, from focused, time-bound assessments to ongoing strategic advisory support.
CRL Compass precedent scan on a target indication
Competitive opportunity assessment
Regulatory due diligence
Investor diligence Q&A preparation
Quarterly category/trend insights subscription
Multi-deal diligence support
Post-transaction regulatory integration
IPO regulatory-readiness program
More Services
